Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate.
D000818:Animals; D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000936:Antigen-Antibody Complex; D001379:Azathioprine / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology*; D004247:DNA; D006801:Humans; D006968:Hypersensitivity, Delayed; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007116:Immunization, Passive; D007166:Immunosuppressive Agents; D007928:Lethal Dose 50; D008231:Lymphopenia; D008727:Methotrexate / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000936:Antigen-Antibody Complex; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D004247:DNA; D001379:Azathioprine; D008727:Methotrexate